previous compound ID: 156 next compound
InChIKey: ANOMHKZSQFYSBR-UHFFFAOYSA-N
SMILES: C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "SD Macknight" "D Rotin" "JW Hanrahan" "DY Thomas" "J Liao" "R Robert" "E Matthes" "GW Carlile" "J Goepp"

chemical graph of compound 156





CID is 91513
synonyms found at PubChem are:
Hydroxyzine dihydrochloride, 2192-20-3, Hydroxyzine hydrochloride, 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride, Hydroxyzine 2HCl, Arcanax, Neurolax, Vistaject, Vistarex, Vistazine, Alamon, Disron, Quiess, Marax, Atranine A, Vistaril steraject, Vistaril Parenteral, Hydroxyzine (dihydrochloride), Tran-Q dihydrochloride, Ataraxoid dihydrochloride, Tranquizine dihydrochloride, EINECS 218-586-3, AI3-50162, Vistaril (TN), Atarax (TN), W-107513, CHEBI:5819, (+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride, 2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride, Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine [French], Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, dihydrochloride, Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-, QYS, 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride, Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride, Hydroxyzine DiHCl, Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, hydrochloride (1:2), Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2), Prestwick_272, Atarax dihydrochloride, AC1Q3ADT, 163837-38-5, HYDROXIZINE CHLORIDE, Hydroxyzine(dihydrochloride), AC1L3M8D, Hydroxyzine Hydrochloride,(S), SCHEMBL491323, C21H27ClN2O2.2HCl, C21H29Cl3N2O2, CHEMBL3186993, DTXSID2040737, CTK8B4497, HY-B0548A, Hydroxyzine hydrochloride [USAN], ANOMHKZSQFYSBR-UHFFFAOYSA-N, MolPort-001-531-967, HMS1568K08, BCP08800, Hydroxyzine dihydrochloride, >=98%, ANW-45296, Hydroxyzine hydrochloride [USP:JAN], MFCD00058200, s4026, AKOS015846478, Hydroxyzine hydrochloride (JP17/USP), AC-8086, AN-8376, API0002955, CCG-220133, CS-2651, HS-0097, 2-(2-{4-[(4-chlorphenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethanoldihydrochlorid, KS-00001F80, NCGC00089816-02, AK-54930, BC204943, H965, LS-66602, AB0005753, AX8032687, KB-220361, ST2403814, TC-063555, FT-0658716, VU0239818-5, D00672, 192H203, SR-01000003137, SR-01000003137-2, Hydroxyzine Hydrochloride 1.0 mg/ml in Methanol (as free base), Hydroxyzine hydrochloride, European Pharmacopoeia (EP) Reference Standard, (+/-)-2-(2-{4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl}ethoxy)ethanol hydrochloride, 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol dihydrochloride, 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride, 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride, Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine, Hydroxyzine Dihydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Hydroxyzine hydrochloride, United States Pharmacopeia (USP) Reference Standard, Hydroxyzine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, AKOS015918229, A815756, I14-7816, 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol; hydron; dichloride, 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]ethanol; hydron; dichloride